Mirabella Financial Services Boosts Vertex Pharmaceuticals Holdings

Institutional investor increases stake in biotech company by 133.9% in third quarter

Mar. 17, 2026 at 11:08am

Got story updates? Submit your updates here. ›

Mirabella Financial Services LLP, an institutional investor, boosted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 133.9% in the third quarter, according to a recent SEC filing. The firm now owns 5,377 shares of the pharmaceutical company's stock, valued at $2.1 million.

Why it matters

Vertex Pharmaceuticals is a leading biotech company focused on developing treatments for serious diseases like cystic fibrosis. The increase in Mirabella's stake suggests the firm sees continued growth potential in Vertex's business and pipeline.

The details

According to the filing, Mirabella Financial Services increased its holdings in Vertex Pharmaceuticals by adding 3,078 shares during the third quarter. The firm now owns a total of 5,377 shares of the pharmaceutical company's stock, valued at $2.1 million.

  • Mirabella Financial Services boosted its stake in Vertex Pharmaceuticals in the third quarter of 2026.

The players

Mirabella Financial Services LLP

An institutional investor that manages a portfolio of investments, including shares in Vertex Pharmaceuticals.

Vertex Pharmaceuticals Incorporated

A Boston-based biotechnology company focused on developing treatments for serious diseases like cystic fibrosis.

Got photos? Submit your photos here. ›

The takeaway

Mirabella Financial Services' increased stake in Vertex Pharmaceuticals suggests the firm sees long-term growth potential in the biotech company's business and pipeline of innovative treatments for serious diseases.